New Zealand - English - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - mometasone furoate monohydrate 51.7ug equivalent to 50 mcg mometasone furoate - nasal spray solution - 50 mcg/dose - active: mometasone furoate monohydrate 51.7ug equivalent to 50 mcg mometasone furoate excipient: benzalkonium chloride citric acid monohydrate dispersible cellulose glycerol polysorbate 80 purified water sodium citrate dihydrate - nasonex nasal spray is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis inadults, adolescents and children between the ages of 3 and 11 years.